Income tax appeal allowed in Dr Lal PathLabs favor
LALPATHLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.8 pts more than Nifty Smallcap 250 and 0.9 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Dr Lal PathLabs has won an income tax appeal before the Commissioner of Income Tax (Appeals). The company had appealed against an assessment order dated March 31, 2024, and the appellate order dated July 16, 2026 (received July 17, 2026) has been passed in the company's favor. A deduction of Rs 32.66 crore claimed on account of ESOP expenses has now been allowed. The company says there is no adverse financial impact as the appeal was decided in its favor.
Positive. A Rs 32.66 crore ESOP expense deduction has been allowed, removing the tax overhang from the March 2024 assessment order.